![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | B3GNT4 | Human | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | ISO | B3gnt4 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | B3GNT4 | Human | 6-propyl-2-thiouracil | decreases expression | ISO | B3gnt4 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of B3GNT4 mRNA | CTD | PMID:24780913 | B3GNT4 | Human | 7,9-dihydro-1H-purine-2,6,8(3H)-trione | affects abundance | EXP | | 6480464 | B3GNT4 gene SNP affects the abundance of Uric Acid | CTD | PMID:23263486 | B3GNT4 | Human | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of B3GNT4 mRNA | CTD | PMID:32763439 | B3GNT4 | Human | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of B3GNT4 promoter | CTD | PMID:30157460 | B3GNT4 | Human | amphotericin B | increases expression | EXP | | 6480464 | Amphotericin B analog results in increased expression of B3GNT4 mRNA | CTD | PMID:28534445 | B3GNT4 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of B3GNT4 promoter | CTD | PMID:30157460 | B3GNT4 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of B3GNT4 5' UTR | CTD | PMID:27901495 | B3GNT4 | Human | bisphenol A | decreases expression | ISO | B3gnt4 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of B3GNT4 mRNA | CTD | PMID:25181051 | B3GNT4 | Human | dioxygen | multiple interactions | EXP | | 6480464 | 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1 more ... | CTD | PMID:24403227 | B3GNT4 | Human | dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of B3GNT4 mRNA | CTD | PMID:24403227 | B3GNT4 | Human | glycidol | decreases expression | ISO | B3gnt4 (Rattus norvegicus) | 6480464 | glycidol results in decreased expression of B3GNT4 mRNA | CTD | PMID:24395379 | B3GNT4 | Human | lead diacetate | increases expression | ISO | B3gnt4 (Rattus norvegicus) | 6480464 | lead acetate results in increased expression of B3GNT4 mRNA | CTD | PMID:22641619 | B3GNT4 | Human | Licochalcone B | increases expression | EXP | | 6480464 | licochalcone B results in increased expression of B3GNT4 mRNA | CTD | PMID:33647349 | B3GNT4 | Human | paracetamol | increases expression | ISO | B3gnt4 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of B3GNT4 mRNA | CTD | PMID:33387578 | B3GNT4 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of B3GNT4 mRNA | CTD | PMID:23557933 | B3GNT4 | Human | sodium arsenite | increases expression | ISO | B3gnt4 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of B3GNT4 mRNA | CTD | PMID:37682722 | B3GNT4 | Human | thiram | decreases expression | EXP | | 6480464 | Thiram results in decreased expression of B3GNT4 mRNA | CTD | PMID:38568856 | B3GNT4 | Human | titanium dioxide | decreases expression | ISO | B3gnt4 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of B3GNT4 mRNA | CTD | PMID:23557971 | B3GNT4 | Human | titanium dioxide | decreases methylation | ISO | B3gnt4 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of B3GNT4 promoter | CTD | PMID:35295148 | B3GNT4 | Human | trichloroethene | increases expression | ISO | B3gnt4 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of B3GNT4 mRNA | CTD | PMID:33387578 | B3GNT4 | Human | triptonide | increases expression | ISO | B3gnt4 (Mus musculus) | 6480464 | triptonide results in increased expression of B3GNT4 mRNA | CTD | PMID:33045310 | |